Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin preconditioning for prevention of postoperative delirium after radical esophagectomy
ChiCTR2200056906Phase 4Not yet recruiting
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin in postoperative delirium (POD) (2 arms), sponsored by General Hospital of Western Theater Command of PLA. Primary endpoints: Total incidence of postoperative delirium within 3 days, NLRP3 mRNA and 2 more. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2200056906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056906.